Evidence map›Paper›PMID 23806757›Full record

ArticleJournal of proteomics2013

Differential expression of proteins in naïve and IL-2 stimulated primary human NK cells identified by global proteomic analysis.

Di Ma, Weifeng Cao, Arvinder Kapur, Mildred Felder, Cameron O Scarlett, Manish S Patankar, Lingjun Li

Abstract read
In one paragraph

Article in Journal of proteomics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Protein networks and activation of lymphocytes.Current opinion in immunology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Di MaSchool of Pharmacy, University of Wisconsin-Madison, 777 Highland Ave., Madison, WI 53705, USA.
Weifeng Cao *Department of Chemistry, University of Wisconsin-Madison, 1101 University Ave., Madison, WI 53706, USA.
Arvinder Kapur *Department of Obstetrics and Gynecology, University of Wisconsin-Madison, 600 Highland Avenue, Madison, WI 53792, USA.
Mildred FelderDepartment of Obstetrics and Gynecology, University of Wisconsin-Madison, 600 Highland Avenue, Madison, WI 53792, USA.
Cameron O ScarlettSchool of Pharmacy, University of Wisconsin-Madison, 777 Highland Ave., Madison, WI 53705, USA.
Manish S PatankarDepartment of Obstetrics and Gynecology, University of Wisconsin-Madison, 600 Highland Avenue, Madison, WI 53792, USA.
Lingjun LiSchool of Pharmacy, University of Wisconsin-Madison, 777 Highland Ave., Madison, WI 53705, USA.
University of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
NCI NIH HHS P30 CA014520
6 · The paper itself

Abstract

Natural killer (NK) cells efficiently cytolyse tumors and virally infected cells. Despite the important role that interleukin (IL)-2 plays in stimulating the proliferation of NK cells and increasing NK cell activity, little is known about the alterations in the global NK cell proteome following IL-2 activation. To compare the proteomes of naïve and IL-2-activated primary NK cells and identify key cellular pathways involved in IL-2 signaling, we isolated proteins from naïve and IL-2-activated NK cells from healthy donors, the proteins were trypsinized and the resulting peptides were analyzed by 2D LC ESI-MS/MS followed by label-free quantification. In total, more than 2000 proteins were identified from naïve and IL-2-activated NK cells where 383 proteins were found to be differentially expressed following IL-2 activation. Functional annotation of IL-2 regulated proteins revealed potential targets for future investigation of IL-2 signaling in human primary NK cells. A pathway analysis was performed and revealed several pathways that were not previously known to be involved in IL-2 response, including ubiquitin proteasome pathway, integrin signaling pathway, platelet derived growth factor (PDGF) signaling pathway, epidermal growth factor receptor (EGFR) signaling pathway and Wnt signaling pathway. BIOLOGICAL SIGNIFICANCE: The development and functional activity of natural killer (NK) cells is regulated by interleukin (IL)-2 which stimulates the proliferation of NK cells and increases NK cell activity. With the development of IL-2-based immunotherapeutic strategies that rely on the IL-2-mediated activation of NK cells to target human cancers, it is important to understand the global molecular events triggered by IL-2 in human NK cells. The differentially expressed proteins in human primary NK cells following IL-2 activation identified in this study confirmed the activation of JAK-STAT signaling pathway and cell proliferation by IL-2 as expected, but also led to the discovery and identification of other factors that are potentially important in IL-2 signaling. These new factors warrant further investigation on their potential roles in modulating NK cell biology. The results from this study suggest that the activation of NK cells by IL-2 is a dynamic process through which proteins with various functions are regulated. Such findings will be important for the elucidation of molecular pathways involved in IL-2 signaling in NK cells and provide new targets for future studies in NK cell biology.

Indexed as

Gene Expression RegulationAntigens, CDCell ProliferationErbB ReceptorsHumansIntegrinsInterleukin-2Killer Cells, NaturalPlatelet-Derived Growth FactorProteomeProteomicsSignal TransductionUbiquitinWnt ProteinsAntigens, CDErbB ReceptorsIntegrinsInterleukin-2Platelet-Derived Growth FactorProteomeUbiquitinWnt ProteinsIL-2 signalingLab-free quantificationMass spectrometry pathwaysMulti-dimensional separationNK cellsProteomics

Identifiers

PMID23806757
PMCPMC4326111
OpenAlexW1963809321

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.